TELA

MKT CAP:$40M

Tela Bio Inc

Market Cap

$40M

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$0.88-$0.26 (-22.81%)

Jun 5, 2026

52W High $2.1452W Low $0.56

Company Details

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company ...

CEO

—

IPO Date

Nov 8, 2019

Website

www.telabio.com

Key Metrics TTM

Revenue

$81M

+13.5% YoY

Net Income

-$40M

EPS (Diluted)

Free Cash Flow

-$30M

Revenue / Share

$1.41

Gross Margin

67.3%

Operating Margin

-41.8%

Net Margin

-49.3%

FCF Margin

-37.4%

P/S

0.5x

P/E

Earnings Reports

Q1 2026

May 13, 2026

$19M+2.9%

FY 2025

Mar 25, 2026

$80M+15.8%

Q4 2025

Mar 25, 2026

$21M+18.2%

Q3 2025

Nov 14, 2025

$21M+9.1%

Q2 2025

Aug 11, 2025

$20M+25.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee